Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Dual and multi-receptor therapies (GLP-1 and GIP) Benefits of GLP-1 and related therapies Who may benefit from GLP-1 therapy Possible side effects Getting treatment in South Africa FAQ What are GLP-1 receptor agonists
Study 7: Hadley & Dorr 2006, historical review Citation: Hadley M.E., Dorr R.T
Source: STEP 1 Clinical Trial (N Engl J Med 2021)
In one phase III study, participants on semaglutide 2.4 mg reported an average weight loss of 16.0% compared to 5.7% for the placebo group
Emface Using similar technology to that of Emsculpt NEO, Emface stimulates muscle contractions to give your facial features a naturally voluminous lift
US$ 21.21
US$ 24.53
US$ 25.47
